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1. Introduction 
Two parallel observations have historically linked poor air quality to human disease. The 
first of these is the recognition that substances in inspired air can pose health risks, and the 
second is the view that growing industrialization at the global level has contributed to 
deteriorating air quality. In the case of the latter, environmental scientists, economists and 
urban planning experts have spoken and written about the impact of industrial growth, 
income and urban development in the context of an “EKC” relationship (Environmental 
Kuznets Curve; “inverted U shaped” curve). This concept is predicated on the fact that as 
human activities related to industry and urban growth increase, an initial and sharp 
deterioration in air quality ensues. Subsequently, as income levels in a society inevitably 
rise, regulation, awareness and increasing attitudes of social and environmental 
responsibility intervene and the air quality standards improve 1. However, since many 
emerging economies and industrial powers (such as China and Brazil) find themselves on 
the left-hand limb of the curve, the consequent impact of their industrial growth and urban 
expansion contribute to the aggregate decline in global air quality and pollution. 
2. Historical perspective 
It is believed that in 1872 Smith published the first scientific report of air pollution 2. This 
and subsequent studies have laid the foundation for the scientific examination of pollutants 
as hazardous components of breathable air and its impact on human populations. In 
subsequent decades, particularly in the 20th century, several major incidents came to 
prominence which underscored the importance of air pollution in human health. For 
example, in 1930 a combination of high atmospheric pressure and mild winds created a 
heavy fog in Belgium. It is estimated that about 60 deaths were attributable, directly or 
indirectly to this significant fog event. Later investigations revealed that trapped potent 
pollutants from chimney exhausts created a toxic cloud that resulted in these fatalities 2. 
Seven years later in 1948, an industrial accident caused 20 deaths with thousands of acute 
illnesses reported because of the smelting plant in Pennsylvania3. Another severe event 
occurred in London in 1952 when pollutants from the use of stoves as well as from 
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industrial plants nearly paralyzed the city. It is estimated that there was a 48% increase in 
hospital admissions and 163% increase in respiratory illnesses resulting in direct hospital 
admissions. This event was soon followed by significant increase in numbers of deaths from 
respiratory illnesses. Such incidents and other related events prompted the establishment of 
clean air and air quality acts in the United States in 1963 and 1967. 
3. Ambient air particulate pollutants and their classification 
Particulate pollution in inspired air comprises coarse and fine particles of various sizes. 
Particles that are considered significant, usually have an aerodynamic diameter (AD) of 
between 2.5 and 10 µ (PM10). Finer particles are those that are less than 2.5 µ (PM2.5), while 
ultrafine particles have aerodynamic diameters of less than 0.1 µ (UFPs). The chemical 
nature and composition of these particles exhibits tremendous diversity and depends on 
numerous geographical, meteorological and source specific variables. In a general sense, 
ambient particles include inorganic components such as sulfates, nitrates, ammonium, 
chloride, and trace metals. In addition, organic materials, crystalline compounds, and 
biological components are also observed.  
The sources of particulate air pollutants can be human, biological but nonhuman, and 
natural. PM10 particles generally relate to human activities and come from dust, burning of 
wood, construction and demolition sites, and from sites involved in mining operations. For 
the size of particle, natural sources include windblown dust and wildfires. Finer particles 
are generally generated by gaseous materials when they convert to particulate phases 
during combustion of fuel and industrial activities. PM2.5 sources include power plants, oil 
refineries, metal processing facilities, automobile exhaust, residential fuel combustion, as 
well as wildfires. The primary sources of UFP is automobile tailpipe emissions from a 
variety of vehicles, including aircraft and marine vessels 2. 
With regard to human health, of particular importance are particles that are equal to or less 
than 10 µ in diameter, because these ultimately enter the lung parenchyma4. As mentioned 
above, particles of 10 µ aerodynamic diameters and smaller can be further divided based on 
size and biological effect. Coarse particles range in size from 2.5 to 10 µ, fine particles are less 
than 2.5 µ in diameter, and ultrafine particles are less than 0.1 µ. Because of their very small 
size, particles that are between 0.1 and 2.5 µ are deeply inhaled into the lung parenchyma. If 
these inhaled particles get deposited in the alveoli they enter the pulmonary circulation and 
are presumed to also continue to the systemic circulation. This indirect observation has been 
the presumed mechanism through which particulate pollution impacts the cardiovascular 
system, which has been reported in a series of major EP immunological and observational 
studies5-7. Recently, considerable research and attention has been given to ultrafine particles 
as well. These UFPs are less than .1 µ in aerodynamic diameter and are usually attributable 
to combustion processes from the burning of fossil fuels, for example. These ultrafine 
particles tend to be short-lived, because they agglomerate and coalesce into larger particles 
rather quickly8. However, these pollutants exhibit a very high rate of deposition in human 
alveoli and account for a major proportion of the actual numbers of particles in the lung. 




Air Pollution and Cardiovascular Diseases 
 
359 
4. Air pollution and disease: Evidence from laboratory studies 
While a large number of epidemiological studies have clearly implicated particulate air 
pollutants in the etiology of human cardiovascular disease, controversy remains regarding 
the underlying biological mechanisms that might explain this phenomenon. Several distinct 
mechanisms have been hypothesized: 
1. Inflammation, oxidative stress, and endothelial function. It has been established that inhaled 
particles can induce inflammation in the lung parenchyma, either directly or by 
generating free oxygen radicals and increasing oxidative stress, particularly by 
activating NAD(P)H oxidase10. Activation of this oxidase in turn triggers intracellular 
signaling pathways such as those of MAP kinases and oxidation sensitive transcription 
factors, such as NFκB and API which control the expression of several genes coding for 
proinflammatory factors. These include but are not limited to, cytokines, particularly, 
interleukin 1ǃ, interleukin 6, and interleukin 8. In addition, TNFǂ and granulocyte-
macrophage colony-stimulating factor (GM-CSF), chemokines, and adhesion molecules 
are also robustly expressed by the signaling systems11, 12. These signaling events are 
critically linked to macrophage and epithelial cell function at the level of pulmonary 
alveoli and bronchi. Once particulate material inspired air reaches these locations, in 
systemic as well as local inflammation ensues. These inflammatory changes are 
evidenced by acute rises in C-reactive protein and fibrinogen as well as increased 
viscosity of plasma. Stimulation of bone marrow with leukocytosis and circulating 
immature polymorphonuclear neutrophils, and activated platelets and other 
procoagulant factors are also involved in this process10. It has been demonstrated, for 
example, that exposure to exhaust from diesel engines contains ingredients that 
attenuate the acute release of tissue plasminogen activator (t-PA) by the endothelium, 
resulting in diminished endogenous fibrinolytic capacity10. In blood vessels, particulate 
matter, causes, endothelial dysfunction by inhibiting the formation of nitric oxide, and 
stimulating the production of endothelin 1, angiotensin II, and thromboxane A213, 14. 
Angiotensin II, in turn, contributes further to oxidative stress, by increasing the 
generation of superoxide and through the enhancement of NAD(P)H oxidase activity. 
These are some of the possible explanations for alterations in endothelium-dependent 
vasomotor activity induced by particulate pollution. Several studies have demonstrated 
endothelium-independent alterations as well, which are also related to mechanisms of 
vasoactivity, such as through the stimulation of sympathetic ennervation as well as by 
the direct stimulation of angiotensin II AT1 receptors. Cumulatively, these alterations 
contribute to the development and progression of atherosclerosis, the destabilization of 
atherosclerotic plaques, and promotion of ischemia antithrombotic states15. Experimental 
models have confirmed that atherosclerosis progresses quite rapidly and plaques have a 
greater vulnerability to rupture in laboratory animals exposed to PM2.5 and PM10 air 
pollution over a period of several weeks or several months. In fact, C-reactive protein, 
which is an acute phase reactant, has been shown to express in greater quantities in the 
presence of particulate pollution. CRP is a known cardiovascular risk factor because it 
facilitates its uptake of lipids by macrophages and the expression has been associated 
with increased fragility atherosclerotic plaques leading to destabilization16. Investigators 
have found a direct correlation between the severity of coronary and aortic atherosclerosis 
and the number of alveolar macrophages that phagocytose PM10 over several weeks 
exposure in rabbits who have heritable hyperlipidemia10. 
www.intechopen.com
 
Air Pollution – Monitoring, Modelling and Health 
 
360 
Several other studies have found that ultrafine particles alongside soluble components 
can also reach the systemic circulation directly and quickly lead to oxidative stress and 
inflammation in the heart and arterial vessels, resulting in endothelial dysfunction, 
without necessarily inducing pulmonary inflammation17. Acute exposure to particles of 
2.5 µ diameter has also been shown to associate with high levels of circulating markers 
of lipid and protein oxidation. 
Investigators have also determined that the inflammatory reaction to inhaled 
particulate material is less due to their mass or volume, but rather is a result of the 
chemical composition and surface area. Fine and ultrafine or even nanoscale particles 
have greater surface areas in proportion to their mass compared with other particles. 
The larger surface area of particles results in greater oxidative stress, which itself is 
consequent upon the larger number of reactive groups present on the surface leading to 
greater synthesis of reactive oxygen species18. 
Researchers have found that the pro-atherogenic effects of particulate pollution 
inhalation, in ApoE deficient mice, results in higher susceptibility to atherosclerotic 
lesions with more significant and more extensive lesions following particulate exposure 
compared with controls. It has been determined that the greater oxidative effect of 
ultrafine particles is related to the higher organic carbon content. In addition, it has also 
been suspected that particles of this small size modulate intracellular calcium 
concentrations by interfering with the opening of calcium channels on cell membranes, 
a phenomenon which itself indirectly leads to the synthesis of reactive oxygen species 
in the cell13. 
The effect of increased oxidative stress, consequent upon exposure to ultrafine particles, 
leads to mitochondrial dysfunction as well. This increases the production of superoxide 
radical and activation of p53, a transcription factor which modulates programmed cell 
death, through the release of pro-apoptotic factors like cytochrome C and AIF. 
2. Autonomic dysfunction: The autonomic nervous system is also particularly susceptible 
to the effect of particulate material in the systemic circulation. For example, 
autonomic dysfunction has been demonstrated after stimulation of pulmonary nerve 
receptors, following exposure to 10 and 2.5 µ particulate materials. These changes 
were shown to be either as a direct effect of the particles, or by the instigation of local 
oxidative stress and inflammation in the lung parenchyma leading to reflex increases 
in heart rate, reduced variability of the heart rate, as well as heart rate rhythm 
anomalies13. 
It has been postulated that the fine and ultrafine particles may also lead to the rhythm 
anomalies in the heart by virtue of their effects on ion channels in cardiac myocytes 13. 
Alternatively, disruption of cardiac autonomic function may also be related to the effect 
of these particles on oxidative homeostasis in the cardiovascular regulatory nuclei in the 
central nervous system19. Intriguingly, the reverse has also been demonstrated in that 
autonomic dysregulation can itself trigger cardiac oxidative stress20. 
3. Dysregulation of intravascular thrombotic system: inhalation of particulate matter has been 
shown to enhance arterial thrombosis and coagulation21. In this regard, empirical work 
has resulted in conflicting data. Some studies have shown a positive correlation 
between particulate matter inhalation and thrombotic dysregulation, while others have 
not17. However, it has been hypothesized that, against the background of vulnerable 
atherosclerotic plaques in individuals who already have these lesions, disturbances of 
the thrombotic milieu, are likely to trigger arterial thrombosis, ischemic events, and 
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catastrophic rupture, leading to embolism. Studies have shown, that increases in 
fibrinogen and blood viscosity, elevated CRP, increased platelet reactivity, altered levels 
of coagulation factors, disturbed histamine levels, enhanced interleukin 6 dependent 
signaling, expression of adhesion molecules, and attenuated release of fibrinolytic 
factors all appear to be mechanistic underpinnings of the impact of particulate matter 
on the cardiovascular system22, 23. One aspect of these mechanistic theories remains 
unresolved. It is not known, what relative roles are played by systemic inflammation, 
disturbed autonomic balance, and the effect of blood-borne mediators of thrombosis, on 
overall cardiovascular health and disease8. 
4. PM and heart failure: exposure to particulate air pollution has also been linked to an 
increased risk of heart failure as well as hospital admissions resulting from heart 
failure24. It is believed that both pro-ischemic, and dysrhythmic effects of particulate 
exposure could be responsible for these phenomena. However, a more recent study in 
mice has also shown that the deposition of particulate material in lung parenchyma can 
impair the ability of the alveoli to clear fluid because of reduced membrane Na-K-
ATPase activity25. In these experiments, this effect was abrogated by the use of 
antioxidants, suggesting that oxidative stress, might play a primary role in such 
phenomena. 
5. Evidence implicated PM in blood pressure regulation: in animal studies, evidence has been 
accumulating that relates particulate air pollution exposure to induced changes in blood 
pressure. For example, in a Sprague-Dawley rat model, where, angiotensin II was 
employed to induce hypertension, exposure to concentrated 2.5 µ the particulate 
pollution for 10 weeks, caused prolonged blood pressure compared with control 
groups26. In this study, aortic vasoconstriction in response to particulate exposure was 
potentiated with exaggerated relaxation to the Rho-kinase inhibitor Y-27632. Investigators 
in this paper also demonstrated an increase in ROCK-1 messenger RNA levels and 
superoxide production in animals exposed to PM, suggesting that even short-term 
exposure to PM can induce hypertension via superoxide-mediated upregulation of the 
Rho/ROCK signaling pathway. In other studies, in Murine models of PM exposure, 
angiotensin II, infusion in conjunction with a rho kinase antagonist, potentiation of the 
hypertensive phenotype was also reported27. Other studies have also shown that exposure 
to 2.5 µ particulate material increases angiotensin II-induced cardiac hypertrophy, 
collagen deposition, cardiac RhoA activation, and vascular RhoA activation, suggesting 
that cardiovascular health effects are consequences of air pollution4. 
5. Air pollution and disease: Evidence from epidemiological studies 
A large number of studies have focused on the acute effects of air pollution. In one study, 
which was carried out in as many as 29 European cities with 43 million inhabitants 
demonstrated that for each 10 µg per cubic meter increase in 10 µ particulate matter, 
cardiovascular mortality rose by 69%28. In the United States, a survey of 90 cities with 15 
million participants revealed a short-term increase in cardiopulmonary mortality of .31% for 
each 10 µg per cubic meter increase in PM10 when measured over a 24-hour period29. Many 
other studies have also demonstrated significant rises of between .8% and .7% respectively 
in hospital admissions from heart failure and ischemic heart disease for every 10 µg per 
cubic meter rise in PM1030. The studies have also shown an increase of 1.28% and 4.5%, 
respectively, and risk of heart failure and acute coronary syndromes for every 10 µg per 
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cubic meter rise in PM2.530. Furthermore, links have also been discovered between short-
term rises in PM 2.5 and the incidence of myocardial infarction, occurring within a few 
hours. Following exposure, ST-segment depression occurs during exercise testing in 
patients with stable coronary disease, increased heart rates, enhanced incidence of 
arrhythmias in several different studies31. Overall, it has been estimated that between 
60,000 and 350,000 sudden cardiac deaths in the United States occur which can be 
attributed to particulate air pollution. 
Investigators have found that exercise-induced myocardial ischemia is exacerbated when 
humans are exposed to diesel exhaust products which are mainly composed of ultrafine 
particles, in concentrations similar to those found in heavy traffic in large urban centers (300 
µg per cubic meter)22. Links have also been demonstrated between pollution from fine 
particles found in motor vehicle emissions and ST-segment depression recorded via Holter 
ECG monitoring32. In addition, a higher incidence of ischemic and hemorrhagic stroke has 
also been reported with higher mortality and more hospital admissions, directly connected 
to short-term increase in airborne PM 1033. In a study undertaken in nine US cities of 
individuals older than 65 years demonstrated that there was a strong association with 
ischemic stroke, with a rise of 1.03% in hospital admissions for every 23 µg per cubic meter 
increase in PM 1034. In this study an association was also found between specific gaseous co-
pollutants and increase in ischemic stroke (carbon monoxide [CO] nitrous oxide [NO2] and 
sulfur dioxide [SO2]). Indeed, several others have reported links between levels of these 
gaseous pollutants and mortality or hospitalization rates due to stroke, as well as re-
hospitalization in survivors of myocardial infarction10. In Germany during the 1985 air 
pollution episode, epidemiological observations revealed that plasma viscosity, heartrate, 
and concentrations of C-reactive protein, were increased during this episode35. In the United 
States, in the city of Boston, nitrogen dioxide in the atmosphere and PM2.5 were associated 
with life-threatening cardiac arrhythmias, leading to the need for drug interventions, 
including the implantation of cardioverter defibrillators. In addition PM2.5 concentrations 
were noted to be higher in the hours and days before onset of myocardial infarction in a 
large group of patients36, 37. In a study of individuals older than 65 years, a positive 
association between stroke mortality and the concentration of fine particles was also 
demonstrated. In this study, a rise of 6.9% for each interquartile increase in PM2.5 on the 
day of death, and a 7.4% increase in the 24 hours prior to death, was demonstrated10. Such 
observations have been made on other continents and in other countries as well outside the 
strict confines of the Western hemisphere. For example, in studies in Shanghai, levels of 
PM2.5 have been reported to influence daily overall cardiopulmonary mortality, this effect 
was not observed for particles smaller than 2.5 µ10. In other Asian countries as well, rise in 
urban air pollution and the rise of cardiovascular morbidity has been well documented. In 
order to understand the effect of air pollution on human health on the vast Asian continent 
and in particular in countries where a sixth to a fifth of humanity reside (namely China and 
India), the Health Effects Institute (a Boston based, U.S. non-profit health research 
corporation) funded the large PAPA (Public Health and Air Pollution in Asia) study. The 
first phase of this project was undertaken in Thailand from 1999 to 2003, in Hong Kong in 
China from 1996 to 2004, and in Shanghai and Wuhan in China between 2001 and 2004 38. 
This study documented several common pollutants such as NO2, SO2 and PM<10μ and their 
effect on cardiovascular and respiratory mortality. One interesting conclusion of the 
investigators (speculative) was that Asian populations might be exposed to outdoor air 
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pollution to a larger extent than Western cohorts because they tend to spend more time 
outside than indoors while Westerners have more access to air conditioning which tends to 
mitigate pollution with the use of filters and recirculated ventilation. In the initial data 
published in the PAPA study, Wuhan in mainland China exhibited highest concentrations 
of PM10 and O3, while Shanghai has the highest concentrations of NO2 and SO2. In 
comparison with cities of comparable size in the U.S. (analyzing data from the National 
Morbidity and Mortality and Air Pollution Study {NMMAPS}), the concentrations of PM10 
and SO2 were found to be much higher for cities included in the PAPA study. For example, 
the concentrations of PM10 in PAPA had means of 52-142 μg/m3 versus 33 μg/m3 in 
NMMAPS. In the case of NO2 and O3, the results were similar in that U.S. had lower 
concentrations than those in China 38. When these results were correlated with mortality 
figures for cardiovascular and respiratory diseases, predictable patterns emerged. Cause of 
death ratios were the highest in Wuhan (4:1), followed by Shanghai (3:1) with lower figures 
documented for Bangkok and Hong Kong 38. 
Banerjee et al have recently reported from India that exposure to poor air quality can alter 
hematological and immunological parameters negatively. In their study, these investigators 
reported results from 2218 individuals residing in the large urban metropolis of New Delhi 
ranging in age from 21-65 years who were exposed to vehicular exhaust (the main polluter 
of air quality in Asia in general and in India in particular). The authors found the prevalence 
of hypertension 4 fold higher than matched controls (Bannerjee M et al, Int J Hyg Environ 
Health 2011 Sep 16 Epub). Platelet P-selctins were significantly upregulated in this cohort 
while CD4+ T-helper cells and CD19+ B cells were found to be depleted and CD56+ NK 
cells were upregulated. These changes in the immune profile is positively correlated with 
hypercoagulable states and higher cardiovascular risk39. These findings have been 
effectively reproduced in other Indian studies as well. For example, Barman and colleagues 
have recently published data from Lucknow (a city in Northern India) in which PM and 
pollutant heavy metals were also linked to elevated risk of cardiovascular risk 40. Even 
earlier studies have shown strong correlation between air pollution levels and 
cardiovascular risk. Nautiyal et al reported in a study completed in the Indian state of 
Punjab (a pilot study) demonstrated positive correlations between angina pectoris and 
PM10 pollution 41. 
Aside from cardiovascular mortality, other parameters of cardiovascular function have also 
been correlated with greater air pollution. For example, in studies from central Europe, a 
rise in blood pressure at times of greater air pollution has been reported. In the MONICA 
study from Germany, a significant rise in blood pressure was noted in relation with 
particulate air pollution even after adjustment for other cardiovascular risk factors42. 
Significant elevations of diastolic blood pressure in 23 normotensive individuals following 
two hours of exposure to PM2.5 were reported by Urch and colleagues43. In Brazil,, 
monocyte levels also appear to significantly influence systolic, diastolic blood pressure 
levels per quartile of monocyte concentration. In this setting, sulfur dioxide levels were also 
noted to affect blood pressure, validating the importance of gaseous co-pollutants44. 
Intriguingly, a large volume of data also suggests that the deleterious effects of particulate 
air pollution can be aggravated by the presence of cofactors such as diabetes, obesity, 
hypertension, chronic pulmonary disease, and previous cardiovascular disease, as well as an 
additive effect of advancing age45, 46. 
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A consensus seems to be gathering between clinicians and scientists that the adverse 
cardiovascular effects of air pollution depend not only on the concentrations of these 
materials but also on the length of exposure. Prolonged exposure appears to have a 
cumulative effect as well as a stronger impact and more persistent consequences then shorter 
exposure. For example, a decrease in PM2.5 over a period of eight years, was shown to 
significantly attenuate the overall cardiovascular and pulmonary mortality by Laden et al47. 
6. Issues of current and future research focus 
An unresolved question is whether the threshold concentrations of particulate air pollution 
exist below which the risk to the general population dissipates or becomes nonexistent. The 
importance of this idea is that if such thresholds can be identified, then governmental and 
private endeavors to reduce air pollution can be pragmatically set to identifiable goals beyond 
which no further public health benefits would accrue. Some of these issues are now beginning 
to be analyzed based on epidemiological data. The Health Effects Institute (HEI), conducted a 
health study beginning in 1996, which is called the National Morbidity, Mortality, and Air 
Pollution Study (NMMAPS). Subsequent analysis of the study found no evidence of a critical 
threshold for PM10 in daily all-cause and cardiorespiratory mortality48. However, a threshold 
of about 50 µg/m3 was estimated for non-cardiorespiratory causes of death. These and similar 
analyses suggest that the threshold for acute effects of ozone on lung function changes are 
likely to be below 100 μg/m3/hour maximum. 
Several time-series studies have shown a link between day-to-day variations in air pollution 
concentrations and the rate of deaths per day as well as rates of hospital admissions, 
however, more detailed correlation remains unclear. For example, it is not certain, by how 
many days, weeks, or months, such events are increased from baseline49. For example, 
Brunekreef and Holgate have suggested that if deaths occurred just a few days earlier than 
would have occurred without air pollution, the public health significance of these 
correlations would be much less severe than if mortality was reduced by months or years49. 
In contrast, effect estimates have been shown to increase with increasing duration of 
exposure to air pollution, which suggests that there is a stronger effect on mortality in 
comparison with associations between day-to-day variations in air pollution and deaths. 
Other data has also shown that many deaths associated with air pollution occur outside 
hospital settings, which further supports the notion that these individuals were often not 
terminally ill50. 
Another confounding aspect of the relationship between air pollution and cardiovascular 
disease in general is to tease out the difference between time spent indoors from that spent 
outdoors. This is because empirical evidence suggests that indoor pollutant concentrations 
differ both qualitatively and quantitatively from that found out-of-doors. This has become 
the basis of criticisms in that it has been questioned if measurement of air pollution on the 
outside without taking into account exposure indoors, is a valid method of assessing 
exposure to air pollutants. Thus one study found that for particulate matter and gases, there 
was no appreciable association between the day-to-day variation in personal exposure to 
nitrogen dioxide, sulfur dioxide, and ozone51. In this study, ambient PM2.5, nitrogen 
dioxide, sulfur dioxide, and ozone were closely associated with personal PM2.5, strongly 
suggesting that gaseous and PM 2.5 concentrations outdoors act as a surrogate for personal 
exposure to PM2.551. 
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Because of these unresolved questions and large costs associated with reducing air 
pollution, questions regarding the relationship between air pollution and health have 
become an area of considerable debate in recent decades. Early studies have been criticized 
for the analytical approach and lack of adequate controls for confounding variables such as 
weather etc., and US cohort studies have been critiqued for inadequate confounder and co-
pollutant controls as well49. Several re-analyses have been performed on these older studies 
and the HEI has itself partnered with the US automobile industry as well as the federal 
government to attempt to resolve this important debate. In one reanalysis called the 
Philadelphia time-series study, as well as several others revealed new insights into the role 
of weather-related variables as well as that of spatial association between air pollution, 
mortality, and other confounding variables49. 
7. Conclusions 
A wide range of experimental and epidemiological studies have established that air pollution 
is an important determinant of cardiovascular risk and that it can influence more traditional 
risk factors. It has been shown that alterations by air pollution, specially by fine and ultrafine 
particles, significantly contribute to the long-term development and progression of 
atherosclerosis, promotion of atherosclerotic plaques and their instability, and acute 
cardiovascular events such as stroke, myocardial infarction, arrhythmias, and sudden cardiac 
death10. However, several key questions remain. With rapid developments in molecular 
biology, proteomics, and genomics, these questions will likely be clarified within the context of 
complex biological mechanisms involved in cardiovascular injury and their interaction with 
particulate air pollution and gaseous air pollution. Thus it is likely, that with increasing 
understanding of the clinical significance of cardiovascular effects of air pollution, a dual 
approach of abating air pollution as well as using traditional medical tools and pharmaceutical 
strategies will, in the future, help in abrogating cardiovascular risk and reducing the incidence 
of cardiovascular pathology in human communities. 
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